Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size

Meaning of Life in HIV-infected Youths

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Chulalongkorn University
Pediatric department, Chulalongkorn University, Bangkok, Thailand
South East Asia Research Collaboration with Hawaii
Wayne State University
University of Minnesota - Clinical and Translational Science Institute
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01644383
First received: July 17, 2012
Last updated: August 26, 2014
Last verified: August 2014
History of Changes
  Purpose

Logotherapy has never been evaluated in HIV-infected teenagers. In this study, we will evaluate the meaning of life by using The Purpose in Life Test and the affect of logotherapy in HIV infected youth at HIV-NAT, Thai Red Cross AIDS Research Centre and King Chulalongkorn Memorial Hospital.


Condition Intervention
Meaning of Life
 Behavioral: logotherapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Meaning in Life of Youth Infected With HIV

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by The HIV Netherlands Australia Thailand Research Collaboration:

Primary Outcome Measures:
  • PIL score [ Time Frame: week 48 ] [ Designated as safety issue: No ]
    Change of PIL score at baseline and follow up visit between the two arms


Secondary Outcome Measures:
  • QOL [ Time Frame: 48 weeks ] [ Designated as safety issue: No ]
Estimated Enrollment: 40
Study Start Date: February 2011
Estimated Study Completion Date: June 2015
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment arm (logotherapy)
Participants in Arm I will attend the logotherapy group sessions by the trained psychologist for 4 visits (see Table II, III). The number of participants in group sessions will be 20 participants per group.
 Behavioral: logotherapy
Logotherapy is therapy during which the interaction between the therapist and the client centres on the topic of meaning. The problems that the clients experience are presented to the client as inseparable parts of his everyday life. The client is then challenged to discover his/her meaning and to take responsibility in facing up to his/her problem. This approach is aimed at helping the client to deal and understand what his /her existences entail.
No Intervention: Control arm (general health education)
Participants in Arm II will attend the routine health education by the nurse. The number of participants in group session will be 20 participants per group.

Detailed Description:

In the HAART era, HIV infected children can live longer and will grow up to become teenagers. However, some may develop psychosocial problems because they have lost family members, experienced poverty, social discrimination etc. Being a normal teenager is tough and is the most complex period of his/her life. This is the period when most teenagers will find their identity and reasons for living. Therefore it is believed that interventions may help HIV-infected teenagers better deal with life. For this study, logotherapy, a therapy that will help a person to discover his/her purpose in life, live meaningful life, and attain self-esteem was used. The success of the intervention was evaluated by using The Purpose in Life Test.

  Eligibility
Ages Eligible for Study:   16 Years to 24 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age 16-24 years
  2. HIV seropositive
  3. HIV disclosed
  4. Understand Thai language
  5. Parent signed written informed consent

Exclusion Criteria:

  1. Mental or psychological disorder or having active suicidal idea or attempt
  2. Having no permanent address
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01644383

Locations
Thailand
HIV-NAT, the Thai Red Cross AIDS Research Centre
Bangkok, Thailand, 10330
Sponsors and Collaborators
The HIV Netherlands Australia Thailand Research Collaboration
Chulalongkorn University
Pediatric department, Chulalongkorn University, Bangkok, Thailand
South East Asia Research Collaboration with Hawaii
Wayne State University
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: Arunya Tuicomepee, PhD Chulalongkorn University
  More Information

Additional Information:
HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier: NCT01644383     History of Changes
Other Study ID Numbers: HIV-NAT 109
Study First Received: July 17, 2012
Last Updated: August 26, 2014
Health Authority: Thailand: Ethical Committee

Keywords provided by The HIV Netherlands Australia Thailand Research Collaboration:
meaning of life
logotherapy
HIV-infected teenagers
adherence

ClinicalTrials.gov processed this record on February 27, 2015